CD318-targeted CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD318-targeted CAR-T cell therapy, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) [Phase 1, Phase 2]